BUYING OPPORTUNITY!? Gerresheimer crash! RENK correction! Nakiki shares following in the Bitcoin footsteps of Strategy and Metaplanet!

Nakiki electrifies stock investors and the Bitcoin world

Stock investors and the Bitcoin community are keeping a close eye on Nakiki SE. The Company is on the verge of becoming the first German company in the regulated market to implement the successful model of so-called Bitcoin Treasury companies. This concept has already enabled investors worldwide to achieve spectacular price gains. Companies like Strategy (formerly MicroStrategy) from the US and Metaplanet from Japan have demonstrated how Bitcoin can be used as a strategic reserve to generate enormous returns for shareholders. While Bitcoin itself has risen around 725% over the past five years, Strategy, thanks to its consistent Bitcoin strategy, has more than doubled this performance.

Noteworthy: The most significant price increases among young Bitcoin Treasury companies occurred around the time of the first Bitcoin purchases. There, price gains of over 100% were achieved in just a few weeks. This is precisely where Nakiki shares are currently at.

Nakiki plans to enter the Bitcoin market via a bond issue. CEO Andreas Wegerich, a major shareholder, leads the management team in building a significant Bitcoin portfolio. Wegerich, an experienced investment banker with billions in transactions under his belt, has brought Bitcoin professionals such as Marc Guilliard onto the team. Together, they aim to establish Nakiki as a German pioneer in the Bitcoin Treasury segment and are also aiming for a listing on the NASDAQ in the coming year.

At the recent virtual IIF investor conference, the management presented the strategy and opportunities:

https://youtu.be/3dbJ-VYfW40?si=VasxW8IGKmQ8TsRb

In addition to the planned Bitcoin purchases, corporate investments in the Bitcoin universe are expected to generate value appreciation and regular income. With the blockchain company Companexis and the financial portal TopStonks, the investment pipeline is already well filled. With a current price of around EUR 0.70, investors have the opportunity to get in early with a German Bitcoin pioneer.

RENK: Things will get interesting on Thursday

RENK is currently undergoing a correction. The military gear specialist's share price has now lost 30% from its high. The other two German defense champions, Rheinmetall and Hensoldt, have also seen noticeable declines. However, the annual performance for all three shares remains well into triple digits. RENK shares, for example, are still trading 238% above their level at the beginning of the year. There have been no recent operational updates from RENK for some time. But this coming Thursday could prove exciting. According to the financial calendar, developments in the third quarter are expected to be reported in the "Pre-Close Call 9M."

According to marketscreener.com, the average price target of analysts is currently EUR 72. Recently, however, there was a "Sell" recommendation, namely, from Citigroup. The analysts downgraded the rating from "Hold" to "Sell", and see the fair value of the shares at EUR 64. The experts justified the downgrade with declining growth prospects in the US business, particularly in the Vehicle Mobility Solutions segment, where RENK supplies tank and tracked vehicle drives. Citi now anticipates annual growth of only around 4% in this area. This is significantly less than the market consensus of over 20%. Although RENK remains operationally sound, the valuation reflects too much optimism. In the bank's view, the stock is therefore overvalued in the short term. In the long term, it could benefit from rising global defense demand.

Gerresheimer: How much further will it fall?

Gerresheimer's stock appears unable to find a bottom, even after falling 40% in just four weeks.

There are certainly reasons for the decline in the share price. The Company had to lower its forecast for the current year. Instead of revenue growth of up to 5%, management now expects a maximum of 2%. Demand fell short of expectations, particularly in the cosmetics and liquid medication business. The dividend cut and doubts about the Company's operating profitability also reinforced the negative sentiment. Uncertainties about a possible takeover further weigh on sentiment, which has now stalled, and an audit of the balance sheet by BaFin. All of this is weighing on investor confidence.

The slide in the share price makes Gerresheimer one of the weakest stocks in the MDAX, with the share now at its lowest level since 2010.

Most recently, UBS also joined the bears – relatively late in the day. Analysts have downgraded Gerresheimer shares from "Buy" to "Neutral." The price target has been slashed from EUR 75 to EUR 29. The move is justified by the numerous uncertainties. In combination with slower growth, operational issues, and regulatory concerns, this is leading to a reassessment of the Company's valuation.

Nakiki is currently in an exciting phase. If the Company succeeds in executing its strategy as planned, a significantly higher share price should be possible. Investors should wait until Thursday for RENK. As for Gerresheimer, many negative factors are likely already priced in, though a turnaround may still take some time.